Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Immuneering Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 52 | 51 | −1 |
| Shares | 16.1M | 11.9M | −4.26M (−26.4%) |
| Value | $118.6M | $34.3M | −$84.3M (−71.1%) |
New holders (7)
Institutions that held Immuneering Corp at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Manhattan Co | 33,250 | $96.1K | 0.00% |
| UBS Group AG | 28,951 | $83.7K | 0.00% |
| XTX Topco Ltd | 24,885 | $71.9K | 0.01% |
| Jane Street Group, LLC | 13,438 | $38.8K | 0.00% |
| Advisor Group Holdings, Inc. | 1,000 | $2.89K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 4 | $11 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (8)
Institutions that held Immuneering Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| ExodusPoint Capital Management, LP | 26,410 | $194.0K |
| HighTower Advisors, LLC | 23,960 | $176.0K |
| Virtu Financial LLC | 11,409 | $84.0K |
| MetLife Investment Management | 11,257 | $82.7K |
| Mirae Asset Global Investments Co., Ltd. | 11,118 | $81.7K |
| Susquehanna International Group, LLP | 10,603 | $77.9K |
| Metropolitan Life Insurance Co | 1,167 | $8.58K |
| Harbour Investments, Inc. | 25 | $184 |